FDA warned Waxhead Sun Defense Company that its zinc body wash/shampoo is an unapproved, misbranded OTC sunscreen drug.
What happened
In May 2024, FDA reviewed labeling on gowaxhead.com for Waxhead Sun Defense Body Wash. FDA found claims that it provides UVA/UVB/UVC protection and acts as a scalp sunscreen, making it an OTC sunscreen drug. FDA says a sunscreen in shampoo or body wash form is not authorized by the OTC sunscreen order and no approved application exists.
What FDA found
The product's sunscreen claims make it an OTC sunscreen drug, but no FDA-approved application is in effect for it.
FD&C Act section 505, 21 U.S.C. 355A sunscreen in shampoo or body wash form is not among the dosage forms allowed by the OTC sunscreen order, and no FDA order authorizes it.
FD&C Act section 505G(m)(2), 21 U.S.C. 355h(m)(2); OTC Monograph M020Because it does not meet section 505G requirements or have an approved application, FDA calls the product misbranded and says it was introduced into interstate commerce.
FD&C Act sections 502(ee) and 301(a), 21 U.S.C. 352(ee) and 331(a)Labeling also suggests antifungal, dandruff/psoriasis, and acne uses, but no OTC monograph allows that combination with sunscreen.
OTC Monographs M005, M032, and M006
What FDA wants
FDA asks the company to notify CDER in writing within 15 working days of receipt of the steps taken to correct the violations and prevent recurrence, with supporting documents. If it cannot finish within that time, it must explain the delay and give a completion date.
Who should pay attention
- brands selling zinc body wash or shampoo with sun-protection claims
- retailers and online marketplaces listing OTC sunscreen products
- companies using OTC monographs for nonstandard drug dosage forms
This is a summary. Read the original letter on fda.gov.